Personalis – Healthcare Data News

Personalis and Tempus Announce Expanded Collaboration

Tempus invests $36 million by exercising warrants and purchasing additional shares August 16, 2024 08:30 AM Eastern Daylight Time FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL) and Tempus AI, Inc. (Nasdaq:...

November 28, 2023December 20, 2023 Collaborations Competitor News

Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

November 28, 2023 04:15 PM Eastern Standard Time FREMONT, Calif. & CHICAGO–(BUSINESS WIRE)–Personalis, Inc., a leader in advanced genomics for precision oncology (Nasdaq: PSNL), and Tempus Labs, Inc., a leader in...